Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Smoking

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 75 articles:
HTML format



Single Articles


    April 2021
  1. WANG TW, Gentzke AS, Neff LJ, Glidden EV, et al
    Disposable E-Cigarette Use among U.S. Youth - An Emerging Public Health Challenge.
    N Engl J Med. 2021;384:1573-1576.
    PubMed    


    October 2020
  2. REDFIELD RR, Hahn SM, Sharpless NE
    Redoubling Efforts to Help Americans Quit Smoking - Federal Initiatives to Tackle the Country's Longest-Running Epidemic.
    N Engl J Med. 2020;383:1606-1609.
    PubMed    


    August 2020
  3. LAYDEN JE, Meiman JG
    Pulmonary Disease Related to E-Cigarette Use. Reply.
    N Engl J Med. 2020;383:793.
    PubMed    


  4. KENNEDY J, Leikin J
    Pulmonary Disease Related to E-Cigarette Use.
    N Engl J Med. 2020;383:792-793.
    PubMed    


    May 2020
  5. SINDELAR JL
    Regulating Vaping - Policies, Possibilities, and Perils.
    N Engl J Med. 2020;382:e54.
    PubMed    


    April 2020
  6. STANBROOK MB, Drazen JM
    Vaping-Induced Lung Disease - A Look Forward by Looking Back.
    N Engl J Med. 2020;382:1649-1650.
    PubMed    


  7. WERNER AK, Koumans EH, Chatham-Stephens K, Salvatore PP, et al
    Hospitalizations and Deaths Associated with EVALI.
    N Engl J Med. 2020;382:1589-1598.
    PubMed     Abstract available


  8. BARROS N, McDermott S, Wong AK, Turbett SE, et al
    Case 12-2020: A 24-Year-Old Man with Fever, Cough, and Dyspnea.
    N Engl J Med. 2020;382:1544-1553.
    PubMed    


    March 2020
  9. BHAT TA, Kalathil SG, Bogner PN, Blount BC, et al
    An Animal Model of Inhaled Vitamin E Acetate and EVALI-like Lung Injury.
    N Engl J Med. 2020;382:1175-1177.
    PubMed    


  10. CHRISTIANI DC
    Vaping-Induced Acute Lung Injury.
    N Engl J Med. 2020;382:960-962.
    PubMed    


  11. LAYDEN JE, Ghinai I, Pray I, Kimball A, et al
    Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Final Report.
    N Engl J Med. 2020;382:903-916.
    PubMed     Abstract available


    February 2020
  12. GORDON T, Fine J
    Cornering the Suspects in Vaping-Associated EVALI.
    N Engl J Med. 2020;382:755-756.
    PubMed    


  13. KING BA, Jones CM, Baldwin GT, Briss PA, et al
    The EVALI and Youth Vaping Epidemics - Implications for Public Health.
    N Engl J Med. 2020;382:689-691.
    PubMed    


  14. HARTNETT KP, Kite-Powell A, Patel MT, Haag BL, et al
    Syndromic Surveillance for E-Cigarette, or Vaping, Product Use-Associated Lung Injury.
    N Engl J Med. 2020;382:766-772.
    PubMed    


  15. BLOUNT BC, Karwowski MP, Shields PG, Morel-Espinosa M, et al
    Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI.
    N Engl J Med. 2020;382:697-705.
    PubMed     Abstract available


    January 2020
  16. DE KONING HJ, van der Aalst CM, de Jong PA, Scholten ET, et al
    Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
    N Engl J Med. 2020 Jan 29. doi: 10.1056/NEJMoa1911793.
    PubMed     Abstract available


  17. LARSEN BT, Butt YM, Smith ML
    More on the Pathology of Vaping-Associated Lung Injury. Reply.
    N Engl J Med. 2020;382:388-390.
    PubMed    


  18. DAVIDSON KR, Fox DL
    More on the Pathology of Vaping-Associated Lung Injury.
    N Engl J Med. 2020;382:388.
    PubMed    


  19. MARSDEN L, Michalicek ZD, Christensen ED
    More on the Pathology of Vaping-Associated Lung Injury.
    N Engl J Med. 2020;382:387-388.
    PubMed    


  20. LAYDEN JE, King BA, Meiman J
    Pulmonary Illness Related to E-Cigarette Use. Reply.
    N Engl J Med. 2020;382:386.
    PubMed    


  21. RUSSELL CD, Cevik M
    Pulmonary Illness Related to E-Cigarette Use.
    N Engl J Med. 2020;382:385-386.
    PubMed    


  22. DIAZ CD, Carroll BJ, Hemyari A
    Pulmonary Illness Related to E-Cigarette Use.
    N Engl J Med. 2020;382:384-385.
    PubMed    


    December 2019
  23. EAPEN MS, Sohal SS
    Update on the Pathogenesis of COPD.
    N Engl J Med. 2019;381:2483-2484.
    PubMed    


  24. HALLOWELL RW, Feldman MB, Little BP, Karp Leaf RS, et al
    Case 38-2019: A 20-Year-Old Man with Dyspnea and Abnormalities on Chest Imaging.
    N Engl J Med. 2019;381:2353-2363.
    PubMed    


    October 2019
  25. BUTT YM, Smith ML, Tazelaar HD, Vaszar LT, et al
    Pathology of Vaping-Associated Lung Injury.
    N Engl J Med. 2019;381:1780-1781.
    PubMed    


  26. HSWEN Y, Brownstein JS
    Real-Time Digital Surveillance of Vaping-Induced Pulmonary Disease.
    N Engl J Med. 2019;381:1778-1780.
    PubMed    


  27. MADDOCK SD, Cirulis MM, Callahan SJ, Keenan LM, et al
    Pulmonary Lipid-Laden Macrophages and Vaping.
    N Engl J Med. 2019;381:1488-1489.
    PubMed    


  28. HENRY TS, Kanne JP, Kligerman SJ
    Imaging of Vaping-Associated Lung Disease.
    N Engl J Med. 2019;381:1486-1487.
    PubMed    


  29. MIECH R, Johnston L, O'Malley PM, Bachman JG, et al
    Trends in Adolescent Vaping, 2017-2019.
    N Engl J Med. 2019;381:1490-1491.
    PubMed    


    September 2019
  30. AGUSTI A, Hogg JC
    Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease.
    N Engl J Med. 2019;381:1248-1256.
    PubMed    


  31. TAZAWA R, Ueda T, Abe M, Tatsumi K, et al
    Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
    N Engl J Med. 2019;381:923-932.
    PubMed     Abstract available


    May 2019
  32. PRZULJ D, Hajek P, Phillips-Waller A
    E-Cigarettes versus Nicotine-Replacement Therapy for Smoking Cessation. Reply.
    N Engl J Med. 2019;380:1974-1975.
    PubMed    


  33. GOTTLIEB MA
    E-Cigarettes versus Nicotine-Replacement Therapy for Smoking Cessation.
    N Engl J Med. 2019;380:1974.
    PubMed    


  34. STEIN JH, Korcarz CE
    E-Cigarettes versus Nicotine-Replacement Therapy for Smoking Cessation.
    N Engl J Med. 2019;380:1973-1974.
    PubMed    


  35. ZHANG Y, Upson D
    E-Cigarettes versus Nicotine-Replacement Therapy for Smoking Cessation.
    N Engl J Med. 2019;380:1973.
    PubMed    


    February 2019
  36. BORRELLI B, O'Connor GT
    E-Cigarettes to Assist with Smoking Cessation.
    N Engl J Med. 2019;380:678-679.
    PubMed    


  37. GHOSH TS, Tolliver R, Reidmohr A, Lynch M, et al
    Youth Vaping and Associated Risk Behaviors - A Snapshot of Colorado.
    N Engl J Med. 2019;380:689-690.
    PubMed    


  38. HAJEK P, Phillips-Waller A, Przulj D, Pesola F, et al
    A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy.
    N Engl J Med. 2019;380:629-637.
    PubMed     Abstract available


  39. DRAZEN JM, Morrissey S, Campion EW
    The Dangerous Flavors of E-Cigarettes.
    N Engl J Med. 2019;380:679-680.
    PubMed    


  40. CROYLE RT, Morgan GD, Fiore MC
    Addressing a Core Gap in Cancer Care - The NCI Moonshot Program to Help Oncology Patients Stop Smoking.
    N Engl J Med. 2019;380:512-515.
    PubMed    


    January 2019
  41. MIECH R, Johnston L, O'Malley PM, Bachman JG, et al
    Adolescent Vaping and Nicotine Use in 2017-2018 - U.S. National Estimates.
    N Engl J Med. 2019;380:192-193.
    PubMed    


    December 2018
  42. RAWSHANI A, Rawshani A, Gudbjornsdottir S
    Smoking and Other Risk Factors in Type 2 Diabetes.
    N Engl J Med. 2018;379:2575.
    PubMed    


  43. HU Y, Hu FB, Sun Q
    Smoking and Other Risk Factors in Type 2 Diabetes.
    N Engl J Med. 2018;379:2574-2575.
    PubMed    


  44. KANNT A
    Smoking and Other Risk Factors in Type 2 Diabetes.
    N Engl J Med. 2018;379:2574.
    PubMed    


  45. MANSI IA
    Smoking and Other Risk Factors in Type 2 Diabetes.
    N Engl J Med. 2018;379:2573-2574.
    PubMed    


  46. FAN T, Yang S, Geng Q
    Smoking and Other Risk Factors in Type 2 Diabetes.
    N Engl J Med. 2018;379:2573.
    PubMed    


  47. ANKER MS, Kalantar-Zadeh K, Doehner W
    Smoking and Other Risk Factors in Type 2 Diabetes.
    N Engl J Med. 2018;379:2572-2573.
    PubMed    


    September 2018
  48. AL-KINDI S, Al-Juhaishi T, Yaqoob Z
    Incidence of Lung Cancer among Young Women.
    N Engl J Med. 2018;379:988-9.
    PubMed    


  49. BERLIN I
    Incidence of Lung Cancer among Young Women.
    N Engl J Med. 2018;379:988.
    PubMed    


  50. FUNATOGAWA I
    Incidence of Lung Cancer among Young Women.
    N Engl J Med. 2018;379:988.
    PubMed    


  51. BIONDI-ZOCCAI G, Peruzzi M, Frati G
    E-Cigarettes, Incentives, and Drugs for Smoking Cessation.
    N Engl J Med. 2018;379:991-2.
    PubMed    


  52. BANDARA NA, Mehrnoush V
    E-Cigarettes, Incentives, and Drugs for Smoking Cessation.
    N Engl J Med. 2018;379:991.
    PubMed    



  53. Incidence of Lung Cancer among Young Women.
    N Engl J Med. 2018;379:988-991.
    PubMed    


  54. HALPERN SD, Volpp KG
    E-Cigarettes, Incentives, and Drugs for Smoking Cessation.
    N Engl J Med. 2018;379:992.
    PubMed    


    August 2018
  55. SCHROEDER SA
    Heavier but Healthier - Diabetes and Smoking Cessation.
    N Engl J Med. 2018;379:684-685.
    PubMed    


  56. HU Y, Zong G, Liu G, Wang M, et al
    Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality.
    N Engl J Med. 2018;379:623-632.
    PubMed     Abstract available


  57. RAWSHANI A, Rawshani A, Franzen S, Sattar N, et al
    Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2018;379:633-644.
    PubMed     Abstract available


    June 2018
  58. HALPERN SD, Harhay MO, Saulsgiver K, Brophy C, et al
    A Pragmatic Trial of E-Cigarettes, Incentives, and Drugs for Smoking Cessation.
    N Engl J Med. 2018;378:2302-2310.
    PubMed     Abstract available


    May 2018
  59. JEMAL A, Miller KD, Ma J, Siegel RL, et al
    Higher Lung Cancer Incidence in Young Women Than Young Men in the United States.
    N Engl J Med. 2018;378:1999-2009.
    PubMed     Abstract available


  60. APELBERG BJ, Feirman SP, Salazar E, Corey CG, et al
    Potential Public Health Effects of Reducing Nicotine Levels in Cigarettes in the United States.
    N Engl J Med. 2018;378:1725-1733.
    PubMed    


    March 2018
  61. CHAN KCA, Chu SWI, Lo YMD
    Ambient Temperature and Screening for Nasopharyngeal Cancer.
    N Engl J Med. 2018;378:962-963.
    PubMed    


    February 2018
  62. MERRILL TG, Lopez W, Perl SB, Bassett MT, et al
    The Judicial Threat to Public Health Innovation - The Sword of Boreali.
    N Engl J Med. 2018;378:499-501.
    PubMed    


    January 2018
  63. FAIRCHILD AL, Lee JS, Bayer R, Curran J, et al
    E-Cigarettes and the Harm-Reduction Continuum.
    N Engl J Med. 2018;378:216-219.
    PubMed    


    September 2017
  64. GOTTLIEB S, Zeller M
    A Nicotine-Focused Framework for Public Health.
    N Engl J Med. 2017;377:1111-1114.
    PubMed    


  65. KESIMER M, Ford AA, Ceppe A, Radicioni G, et al
    Airway Mucin Concentration as a Marker of Chronic Bronchitis.
    N Engl J Med. 2017;377:911-922.
    PubMed     Abstract available


    January 2017
  66. KASZA KA, Ambrose BK, Conway KP, Borek N, et al
    Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014.
    N Engl J Med. 2017;376:342-353.
    PubMed     Abstract available


    December 2016
  67. POLOSA R, Caponnetto P
    The Health Effects of Electronic Cigarettes.
    N Engl J Med. 2016;375:2608.
    PubMed    


  68. DINAKAR CH, O'Connor GT, et al.
    The Health Effects of Electronic Cigarettes.
    N Engl J Med. 2016;375:2608-2609.
    PubMed    


    October 2016
  69. FIORE MC
    Tobacco Control in the Obama Era - Substantial Progress, Remaining Challenges.
    N Engl J Med. 2016;375:1410-1412.
    PubMed    


    September 2016
  70. WOODRUFF PG, Couper D, Han MK
    Symptoms in Smokers with Preserved Pulmonary Function.
    N Engl J Med. 2016;375:896-7.
    PubMed    


  71. HARZHEIM E, Goncalves MR, Molina-Bastos C
    Symptoms in Smokers with Preserved Pulmonary Function.
    N Engl J Med. 2016;375:896.
    PubMed    


  72. TRINKMANN F, Henzler T, Saur J
    Symptoms in Smokers with Preserved Pulmonary Function.
    N Engl J Med. 2016;375:895-6.
    PubMed    


  73. BOWMAN JS 3RD
    Symptoms in Smokers with Preserved Pulmonary Function.
    N Engl J Med. 2016;375:895.
    PubMed    


  74. FABBRI LM
    Symptoms in Smokers with Preserved Pulmonary Function.
    N Engl J Med. 2016;375:897.
    PubMed    


  75. MARTINEZ FD
    Early-Life Origins of Chronic Obstructive Pulmonary Disease.
    N Engl J Med. 2016;375:871-8.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Smoking is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: